The 20 Best Endophthalmitis Doctors Near Me in Bethesda, MD

Fasika A. Woreta, M.D., M.P.H. is a cornea and cataract specialist and the Eugene de Juan, M.D. Professor of Ophthalmic Education at Wilmer Eye Institute’s Baltimore and Columbia locations. Her expertise is in in corneal and external eye diseases, including complex cataracts and anterior segment reconstruction following trauma. Dr. Woreta is currently the director of the Eye Trauma Center and the director of the Ophthalmology Residency Program at the Wilmer Eye Institute. An associate professor of ophthalmology, Dr. Woreta received her M.D. degree from the Johns Hopkins University School of Medicine and her M.P.H. degree from the Johns Hopkins Bloomberg School of Public Health. She completed her residency in ophthalmology at the Wilmer Eye Institute, then completed a fellowship in cornea and refractive surgery at the Bascom-Palmer Eye Institute at the University of Miami, as well as an accident and emergency and cataract fellowship at Moorfields Eye Hospital. Dr. Woreta is rated as an Elite provider by MediFind in the treatment of Endophthalmitis. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Endophthalmitis, Cataract, Hyphema, Cataract Removal, and Corneal Transplant. Dr. Woreta is board certified in American Board Of Ophthalmology.

Divya Srikumaran, M.D., is the Walter J. Stark Chair of Ophthalmology at the Wilmer Eye Institute, and practices at Wilmer's East Baltimore and Odenton, Maryland locations. She specializes in diagnosing and treating diseases of the cornea, performing corneal transplants, cataract surgeries, and refractive surgeries (LASIK). She is an investigator for several clinical trials at Wilmer offering her patients the latest treatment options. She has published numerous articles in peer-reviewed journals and lectures at national cornea and cataract conferences. Dr. Srikumaran, an associate professor of ophthalmology in the Division of Cornea and External Disease at the Johns Hopkins Wilmer Eye Institute received her M.D. degree from Northwestern University Feinberg School of Medicine, after which she completed her ophthalmology residency and cornea fellowship training at the Wilmer Eye Institute. Dr. Srikumaran’s research interest includes the assessment of corneal transplant outcomes and risk factors for receiving keratoplasty through big data sources including administrative claims data. She received the Hoskins Center IRIS Registry Research Fund Award through the American Academy of Ophthalmology as well as the EBAA Pilot Research grant to study real-world endothelial keratoplasty outcomes. She is a busy clinician who is actively involved in multi-central clinical trials in cornea. In addition, she serves on the scientific program committee of the EBAA and is participating in their Physician Leadership Program. She is also a member of the editorial board for Cornea and will serve as an associate editor for the society’s new journal Cornea Open. She is also a renowned educator and currently serves as Vice Chair of Education and was previously residency program director. As vice chair of education, she has an interest in medical education and studying best practices to support doctors in training and has been awarded several teaching awards. Blending her passion for both education and expertise in corneal surgery, Dr. Srikumaran has also studied barriers to adoption of advanced keratoplasty procedures in the US and abroad. Dr. Srikumaran is also an examiner and member of the cornea and cataract exam content development committees for the American Board of Ophthalmology and was selected to participate in their Visiting Scholar Program. Dr. Srikumaran is rated as a Distinguished provider by MediFind in the treatment of Endophthalmitis. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Cataract, Fuchs Dystrophy, Endophthalmitis, Corneal Transplant, and Cataract Removal. Dr. Srikumaran is board certified in American Board Of Ophthalmology.

Bryn M. Burkholder, M.D., is an assistant professor of ophthalmology at the Wilmer Eye Institute and the Antoinette R. Schifanelli Rising Professor of Ophthalmology, specializing in ocular inflammatory and infectious diseases, cataract surgery and comprehensive ophthalmology. Dr. Burkholder earned her bachelor's degree from Duke University, where she majored in biology, and received her medical degree from the University of Pennsylvania. After completing an internship at the Albert Einstein Medical Center in Philadelphia, she moved to Baltimore for her residency in ophthalmology at the Wilmer Eye Institute. Dr. Burkholder remained at Wilmer for her fellowship training in uveitis before joining the faculty in July 2012. Dr. Burkholder is rated as an Advanced provider by MediFind in the treatment of Endophthalmitis. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Uveitis, Scleritis, Neuroretinitis, Episcleritis, and Cataract Removal. Dr. Burkholder is board certified in American Board Of Ophthalmology.

Yannis M. Paulus, M.D., F.A.C.S., is the Jonas Fridenwald Professor in Ophthalmology, an associate professor in the Johns Hopkins University Department of Ophthalmology and Department of Biomedical Engineering, and a vitreoretinal surgeon at the Wilmer Eye Institute, Johns Hopkins Medicine’s East Baltimore and Columbia locations. Dr. Paulus served as a surgical retina specialist and director of a research laboratory at the University of Michigan Kellogg Eye Center for almost 10 years, where he developed novel imaging systems, lasers and long-lasting therapies and nanotechnologies to allow physicians to determine cellular markers of disease, enabling early diagnosis, improved treatment monitoring and more individualized, personalized precision medicine tailored to each patient’s needs. After earning his bachelor’s degree in chemistry and physics from Harvard University and his medical degree at Stanford University School of Medicine, Dr. Paulus completed an internship at the Sloan-Kettering Cancer Center, a residency in ophthalmology at the Stanford University School of Medicine Byers Eye Institute, and a surgical and medical retina fellowship at Wilmer Eye Institute, Johns Hopkins Medicine. CVhttps://www.hopkinsmedicine.org/-/media/wilmer/documents/cvs/Paulus_CV%2021225.pdf. Dr. Paulus is rated as an Advanced provider by MediFind in the treatment of Endophthalmitis. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Diabetic Retinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Vitrectomy, and Cataract Removal. Dr. Paulus is board certified in American Board Of Ophthalmology.

Meghan Berkenstock, M.D., is an associate professor of ophthalmology at the Johns Hopkins Wilmer Eye Institute. She specializes in ocular inflammatory and infectious diseases, cataract surgery, and comprehensive ophthalmology. Since joining the faculty of the Wilmer Eye Institute in 2016, she has established a research focus on risk reduction and quality assurance initiatives in the care of patients with uveitis. She has implemented several initiatives to improve laboratory monitoring and understanding barriers to care in patients on immunosuppressive medications. The bulk of her research focuses on identifying ocular adverse events (IRAE) associated with the use of immunotherapy agents in the treatment of systemic malignancies. She is a member and the only ophthalmologist on the National Comprehensive Cancer Network Panel on developing guidelines to treat IRAEs. Dr. Berkenstock is rated as an Advanced provider by MediFind in the treatment of Endophthalmitis. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Scleritis, Episcleritis, Uveitis, Vitrectomy, and Cataract Removal. Dr. Berkenstock is board certified in American Board Of Ophthalmology.

Fernando Arevalo is an Ophthalmologist practicing medicine in Baltimore, Maryland. Dr. Arevalo is rated as an Advanced provider by MediFind in the treatment of Endophthalmitis. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Gyrate Atrophy of the Choroid and Retina, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, and Diabetic Retinopathy.

Peter A. Campochiaro, M.D. is the George S. and Dolores Doré Eccles Professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins University School of Medicine. He is a clinician-scientist who directs a research laboratory and conducts clinical trials. His laboratory research is directed at understanding the pathogenesis of ocular neovascularization and excessive retinal vascular permeability, and the mechanism of cone cell death in inherited retinal degenerations. He helped to determine the importance of vascular endothelial growth factor (VEGF), hypoxia-inducible factor-1, and Tie2 in retinal and choroidal vascular diseases. The clinical trial group under Dr. Campochairo provided the first demonstration of the benefits of suppression of VEGF in diabetic macular edema and retinal vein occlusion. He has developed strategies for sustained suppression of VEGF that are currently being tested in clinical trials. Dr. Campochiaro trained at the University of Notre Dame, Johns Hopkins School of Medicine, and the University of Virginia. He did a vitreoretinal fellowship and research fellowships at Johns Hopkins and joined the faculty of the University of Virginia in 1984. He became professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins in 1991. Dr. Campochiaro is rated as an Advanced provider by MediFind in the treatment of Endophthalmitis. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Retinal Vein Occlusion, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Trabeculectomy, and Vitrectomy. Dr. Campochiaro is board certified in American Board Of Ophthalmology.

Zaaira Ahmad is an Ophthalmologist practicing medicine in Salisbury, Maryland. Dr. Ahmad is rated as a Distinguished provider by MediFind in the treatment of Endophthalmitis. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Endophthalmitis, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Vitrectomy, and Cataract Removal.

Eric Weichel is an Ophthalmologist practicing medicine in Bowie, Maryland. Dr. Weichel is rated as a Distinguished provider by MediFind in the treatment of Endophthalmitis. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Retinal Detachment, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Endophthalmitis, and Vitrectomy.

Michael Grodin is an Ophthalmologist practicing medicine in Lutherville Timonium, Maryland. Dr. Grodin is rated as a Distinguished provider by MediFind in the treatment of Endophthalmitis. He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Diabetic Retinopathy, and Retinal Artery Occlusion.

Kenneth Taubenslag is an Ophthalmologist practicing medicine in Baltimore, Maryland. Dr. Taubenslag is rated as a Distinguished provider by MediFind in the treatment of Endophthalmitis. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Endophthalmitis, Neuroretinitis, Uveitis, Trabeculectomy, and Vitrectomy.

Allen Hu is an Ophthalmologist practicing medicine in Cumberland, Maryland. Dr. Hu is rated as an Advanced provider by MediFind in the treatment of Endophthalmitis. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Diabetic Retinopathy, and Vitrectomy. Dr. Hu is board certified in American Board Of Ophthalmology.

Rohit Lakhanpal is an Ophthalmologist practicing medicine in Baltimore, Maryland. Dr. Lakhanpal is rated as an Advanced provider by MediFind in the treatment of Endophthalmitis. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Late-Onset Retinal Degeneration, Diabetic Retinopathy, Age-Related Macular Degeneration (ARMD), Retinal Artery Occlusion, and Vitrectomy.

John Wroblewski is an Ophthalmologist practicing medicine in Hagerstown, Maryland. Dr. Wroblewski is rated as an Advanced provider by MediFind in the treatment of Endophthalmitis. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Retinopathy, and Choroid Plexus Carcinoma. Dr. Wroblewski is board certified in American Board Of Ophthalmology.

Dr. Neil Bressler has been a member of the Wilmer Eye Institute's faculty since 1988 and is the inaugural James P. Gills Professor of Ophthalmology. He specializes in retinal diseases, with special interests in diabetic retinopathy and macular degeneration. Dr. Bressler's main research interests have been collaborative efforts in clinical trials of common retinal diseases, including age-related macular degeneration and diabetic retinopathy, having chaired several NIH-sponsored and industry-sponsored multicenter randomized clinical trials and authored almost 300 peer-reviewed publications. He is a past chair of the NIH-sponsored Diabetic Retinopathy Clinical Research Network, and was responsible for guidelines, policies, protocol development as well as implementation, and to facilitate Network operations in a way that maintains academic integrity and optimal clinical trial performance. He also has chaired the National Eye Institutes Data and Safety Monitoring Committee for intramural clinical trials and the FDA Ophthalmic Devices Panel. Dr. Bressler is currently editor-in-chief of JAMA Ophthalmology. Dr. Bressler is rated as an Experienced provider by MediFind in the treatment of Endophthalmitis. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Diabetic Macular Edema (DME), Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Vitrectomy, and Cataract Removal. Dr. Bressler is board certified in American Board Of Ophthalmology.

James T. Handa, M.D., is Chief of the Retina Division and the Robert Bond Welch, M.D., Professor of Ophthalmology at the Wilmer Eye Institute. He specializes in medical and surgical management of complex vitreoretinal diseases such as age-related macular degeneration, diabetic retinopathy, retinal detachment, retinopathy of prematurity and other pediatric retinal diseases. He also has expertise in intraocular oncology and manages patients with choroidal melanomas and metastatic tumors of the eye. Not only is he a highly skilled surgeon and clinician, but he also devotes significant effort to research related to the early causes of age-related macular degeneration using molecular pathological approaches to understand how the eye transforms from normal aging to early disease. He has been funded by the National Eye Institute for the last 19 years, and he currently holds two R01 awards for his work in AMD. He has also been funded by the Thome Foundation, Research to Prevent Blindness, Fight for Sight and the American Health Assistance Foundation. His other research focuses on surgical innovation using an integrated robotic surgical system. Dr. Handa is currently the Wilmer Eye Institute’s implanting surgeon for the Argus II retinal chip implant, which was recently approved by the FDA after Dr. Handa participated in the clinical trial leading to its approval. Dr. Handa is rated as an Experienced provider by MediFind in the treatment of Endophthalmitis. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Melanoma of the Eye, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Metastatic Uveal Melanoma, and Vitrectomy. Dr. Handa is board certified in American Board Of Ophthalmology.

Dr. Pradeep Ramulu is a glaucoma specialist and the director of the Wilmer Eye Institute glaucoma division. He specializes in caring for both routine and complex glaucomas, including glaucomas requiring repeat operations, glaucoma occurring in the context of corneal or retinal disease and glaucoma occurring in newborns and young children. The Sheila K. West Professor of Ophthalmology at the Wilmer Eye Institute, Dr. Ramulu grew up in suburban Chicago, and became interested in the eye during medical school, during which time he studied the genes and proteins of the eye with Dr. Jeremy Nathans. After pursuing a residency in ophthalmology and fellowship training in glaucoma, he joined Wilmer in 2006. Dr. Ramulu is rated as an Experienced provider by MediFind in the treatment of Endophthalmitis. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Glaucoma, Ocular Hypertension (OHT), Cataract, Iridectomy, and Cataract Removal. Dr. Ramulu is board certified in American Board Of Ophthalmology.

Ashley Behrens, M.D., is the Edward St. John Professor in Ophthalmology and chief of the comprehensive ophthalmology division at the Wilmer Eye Institute, Johns Hopkins Medicine. He specializes in the medical and surgical management of cataracts and corneal diseases, including corneal transplantation techniques for Fuchs’ dystrophy and keratoconus, as well as LASIK, PRK and refractive lens exchange. Dr. Behrens received his medical degree from the Universidad Central de Venezuela in Caracas, and completed his ophthalmology residency and fellowship training at the Francisco Risquez Hospital. He completed additional fellowships at the University of Erlangen-Nuremberg in Germany, where he obtained his German Doctorate with Magna Cum Laude Distinction, and then at the University of Southern California and the University of California, Irvine. Dr. Behrens joined the Wilmer faculty in 2003, and served as executive medical director at the King Khaled Eye Specialist Hospital (KKESH), Wilmer’s affiliate hospital in Saudi Arabia, from July 2010 through August 2014. Dr. Behrens is rated as an Experienced provider by MediFind in the treatment of Endophthalmitis. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Interstitial Keratitis, Cataract, Optic Atrophy Type 1, Vitrectomy, and Cataract Removal.

Mira M. Sachdeva, M.D., Ph.D. specializes in the medical and surgical management of diseases of the retina, including diabetic retinopathy, macular degeneration, retinal vascular occlusions, retinal detachments, macular holes, and epiretinal membranes. Her research efforts are directed towards developing new treatments to prevent or reverse the retinal neurodegeneration and vision loss that occurs in patients with diabetes. Dr. Sachdeva’s ultimate goal is to identify strategies for neuroprotection that are broadly applicable to other conditions in which the retina is irreversibly damaged, including macular degeneration and retinal detachment. Dr. Sachdeva received her medical degree from the University of Pennsylvania medical school. She completed her residency at the Wilmer Eye Institute in 2014. Thereafter, she completed a fellowship at the Massachusetts Ear and Eye Infirmary. Dr. Sachdeva is currently a Wilmer Rising Professor in Ophthalmology. Videos Dr. SachdevaOphthalmology Recent News Articles and Media Coverage Bridging the Gap, Wilmer Magazine (July 2019). Dr. Sachdeva is rated as an Experienced provider by MediFind in the treatment of Endophthalmitis. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Diabetic Retinopathy, Adult-Onset Vitelliform Macular Dystrophy (AVMD), Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), and Vitrectomy. Dr. Sachdeva is board certified in American Board Of Ophthalmology.

T. Y. Alvin Liu, M.D. is the James P. Gills, Jr. M.D., and Heather Gills Rising Professor of AI and the founding director of the Wilmer Precision Ophthalmology Center of Excellence. He is originally from Hong Kong, and speaks fluent Cantonese and Mandarin. He attended Phillips Exeter Academy in Exeter, New Hampshire, and graduated from Cornell University with a dual major in biology and economics. He received his M.D. from Columbia University in 2012, and completed his residency (2016) and fellowship (surgical and medical retina- 2018) at Johns Hopkins. He is subspecialty-trained in the medical and surgical treatment of vitreoretinal diseases, including age-related macular degeneration, diabetic retinopathy, diabetic macular edema, retinal vascular occlusion, retinal detachment, vitreous hemorrhage, epiretinal membrane and macular hole. Dr. Liu's research interests center on the application of artificial intelligence in the screening, diagnosis, prognostication and treatment of ophthalmic diseases, with a specific focus on vitreoretinal diseases such as age-related macular degeneration and diabetic retinopathy. In addition, he is involved in research on the pathogenesis of and treatment for pathologic myopia and the management of severe ocular trauma. Videos Dr. Tin Yan Alvin Liu Recent News Articles and Media Coverage AI Speeds Diabetic Retinopathy Diagnosis Without Specialist. Medscape August 28, 2018 AI Screening for Diabetic Retinopathy Moves to Retail Clinics. Medscape November 26, 2019 How Artificial Intelligence is Primed to Change Ophthalmology. Ophthalmology Advisor May 14, 2021 Medicine's first autonomous AI could prevent blindness due to diabetes. Stat News December 16, 2021 Innovations in Eye Care: How Technology is Transforming Ophthalmology. HealthTech November 29, 2022 Time to go multicultural. Retina Today March 1, 2023 How deep learning may play a role in predicting retinitis pigmentosa visual impairment. Ophthalmology Times March 14, 2023 AI in retinal diagnostics. Zhaoke Ophthalmology March 22, 2023 Macular Degeneration. Spotlight on Geographic Atrophy. Advances in Treatment. WebMD April 23, 2023 ARVO 2023: T.Y. Alvin Liu, MD discusses predictive AI and its application in ophthalmology. Modern Retina April 25, 2023 ASCRS: Prediction of imminent conversion to neovascular AMD using deep learning and 3D OCT volumes. OptometryTimes May 5, 2023 Adopting and regulating AI in healthcare. BNN Bloomberg May 29, 2023 AI could increase health equity and boost adherence to annual eye examination in patients with diabetes. Modern Retina June 21, 2023 As more Marylanders grow older, a debilitating eye disease is gaining ground. The Baltimore Banner June 26, 2023. Dr. Liu is rated as an Experienced provider by MediFind in the treatment of Endophthalmitis. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Usher Syndrome Type 2A, Cone-Rod Dystrophy, Doyne Honeycomb Retinal Dystrophy, and Usher Syndrome. Dr. Liu is board certified in American Board Of Ophthalmology.